Pathogenesis of human cytomegalovirus infection and cellular targets
- 1 May 2004
- journal article
- review article
- Published by Elsevier BV in Human Immunology
- Vol. 65 (5), 381-386
- https://doi.org/10.1016/j.humimm.2004.02.009
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- In Vitro Model for the Study of the Dissociation of Increasing Antigenemia and Decreasing DNAemia and Viremia during Treatment of Human Cytomegalovirus Infection with Ganciclovir in Transplant RecipientsThe Journal of Infectious Diseases, 2003
- Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trialBlood, 2003
- Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial1Transplantation, 2003
- Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn InfantClinical Microbiology Reviews, 2002
- In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia.JCI Insight, 1998
- Cytomegalovirus Infection in Patients with AIDSClinical Infectious Diseases, 1992
- Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cellsJournal of General Virology, 1991
- Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patientsJournal of Medical Virology, 1989
- Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytesJournal of Medical Virology, 1988
- Herpesvirus Infections of PregnancyNew England Journal of Medicine, 1985